Eric E. O'neill

Oxford, ENG OX13QX, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Galectin-3 induces neurodevelopmental apical-basal polarity and regulates gyrification.

Galectin-3 induces neurodevelopmental apical-basal polarity and regulates gyrification.

Journal: Science advances

Published: September 03, 2025

Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinoma.

Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 22, 2025

Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA.

Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA.

Journal: Science (New York, N.Y.)

Published: August 14, 2025

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

Journal: Nature biotechnology

Published: May 08, 2025

ATR-hippo drives force signaling to nuclear F-actin and links mechanotransduction to neurological disorders.

ATR-hippo drives force signaling to nuclear F-actin and links mechanotransduction to neurological disorders.

Journal: Science advances

Published: February 14, 2025

Using Spectral Flow Cytometry to Characterize Anti-Tumor Immunity in Orthotopic and Subcutaneous Mouse Models of Cancer.

Using Spectral Flow Cytometry to Characterize Anti-Tumor Immunity in Orthotopic and Subcutaneous Mouse Models of Cancer.

Journal: Current protocols

Published: October 21, 2024

Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.

Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.

Journal: Gut

Published: July 31, 2024

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy.

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy.

Journal: Science advances

Published: July 05, 2024

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 08, 2024

Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature.

Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature.

Journal: Cancer immunology, immunotherapy : CII

Published: December 07, 2023

Targeted irradiation in an autochthonous mouse model of pancreatic cancer.

Targeted irradiation in an autochthonous mouse model of pancreatic cancer.

Journal: Disease models & mechanisms

Published: September 08, 2023

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer.

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer.

Journal: Cell death and differentiation

Published: November 18, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026